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Background
Oligodendroglial tumors represent approximately 4-7%
of all gliomas, however, in some series the incidence has
been reported to be as high as 10-20% due to improved
histological appreciation and recently recognized mole-
cular signatures. The discovery of 1p and 19q chromo-
somal arms deletion in glial tumors influences both
more objective diagnosis and more accurate prediction
of chemotherapy response. As a result an attempt has
been made to detect deletion using fluorescence in-situ
hybridization (FISH) and to determine its prognostic
value in a cohort of glial tumor patients from Andhra
pradesh.
Materials and Methods
FISH was performed on 66 FFPE tissue sections by
using Vyis LSI 1p36/LSI 1q25 and LSI 19p13/LSI 19q13
dual coloured FISH probe sets. Signals were scored
from at least 150-250 non-overlapping, intact nuclei.
Results
Simultaneous occurrence of both 1p and 19q deletions
was observed in (21/35) 60% of oligodendroglyomas which
included (8/21) 38% of grade II and (13/21) 61.9% of grade
III. Isolated 19q deletion was seen in (1/21) 4.76% & lone
1p loss was not observed in oligodendroglyomas. In Mixed
Oligoastrocytomas combined 1p/19q loss was observed in
(7/16)43.75% cases, including one grade II and 6 grade III
tumors and 1/16 (6.25%) showed isolated 1p loss & 19q
deletion. This disorder was not observed in astrocytomas.
The oligodendroglial phenotype was found to be signifi-
cantly associated with a loss of 1p (P<0.05), a loss of 19q
(P<0.05) and a combined loss of 1p and 19q (P< 0.05).
Frontal location of a tumor occurred to be a statistically
significant factor unfavourable for prognosis, p<0.05.
Conclusion
In the work presented the FISH was successfully applied
to identify deletion 1p/19q. Its incidence depends on the
type of diagnosed glioma. Deletions also have prognostic
significance in the test group what constitutes the basis for
inclusion of determining deletion 1p/19q into diagnostic
and treatment algorithm in gliomas.
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